Ruixia X. Linghu

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

GINS2 regulates matrix metallopeptidase 9 expression and cancer stem cell property in human triple negative Breast cancer.

GINS2 regulates matrix metallopeptidase 9 expression and cancer stem cell property in human triple negative Breast cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 01, 2016

Inhibition of glutathione metabolism attenuates esophageal cancer progression.

Inhibition of glutathione metabolism attenuates esophageal cancer progression.

Journal: Experimental & molecular medicine

Published: August 25, 2016

Efficacy, safety and proper dose analysis of PEGylated granulocyte colony-stimulating factor as support for dose-dense adjuvant chemotherapy in node positive Chinese breast cancer patients.

Efficacy, safety and proper dose analysis of PEGylated granulocyte colony-stimulating factor as support for dose-dense adjuvant chemotherapy in node positive Chinese breast cancer patients.

Journal: Oncotarget

Published: August 20, 2016

Ubiquitin specific protease 21 upregulation in breast cancer promotes cell tumorigenic capability and is associated with the NOD-like receptor signaling pathway.

Ubiquitin specific protease 21 upregulation in breast cancer promotes cell tumorigenic capability and is associated with the NOD-like receptor signaling pathway.

Journal: Oncology letters

Published: May 10, 2016

Docetaxel/S-1 Versus Docetaxel/Capecitabine as First-Line Treatment for Advanced Breast Cancer: A Retrospective Study.

Docetaxel/S-1 Versus Docetaxel/Capecitabine as First-Line Treatment for Advanced Breast Cancer: A Retrospective Study.

Journal: Medicine

Published: October 16, 2015

Combating rituximab resistance by inducing ceramide/lysosome-involved cell death through initiation of CD20-TNFR1 co-localization.

Combating rituximab resistance by inducing ceramide/lysosome-involved cell death through initiation of CD20-TNFR1 co-localization.

Journal: Oncoimmunology

Published: August 21, 2015

Combating HER2-overexpressing breast cancer through induction of calreticulin exposure by Tras-Permut CrossMab.

Combating HER2-overexpressing breast cancer through induction of calreticulin exposure by Tras-Permut CrossMab.

Journal: Oncoimmunology

Published: September 16, 2014

Breast carcinoma with choriocarcinomatous features: a case report and review of the literature.

Breast carcinoma with choriocarcinomatous features: a case report and review of the literature.

Journal: World journal of surgical oncology

Published: October 23, 2013

Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer.

Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer.

Journal: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica

Published: April 16, 2013

Showing 1-9 of 9

Last Updated: 09/26/2026